Jump Financial, LLC Insmed Inc Transaction History

Jump Financial, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $5.89 Million - $7.5 Million	-94,960 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $2.09 Million - $6.62 Million	94,960 New	94,960 $6.36 Million
Q4 2023 Oct 21, 2024	SELL	$23.42 - $31.74 $1.55 Million - $2.1 Million	-66,206 Reduced 62.49%	39,743 $1.23 Million
Q4 2023 Feb 07, 2024	SELL	$23.42 - $31.74 $1.55 Million - $2.1 Million	-66,206 Reduced 62.49%	39,743 $1.23 Million
Q3 2023 Oct 21, 2024	BUY	$19.86 - $26.93 $858,627 - $1.16 Million	43,234 Added 68.94%	105,949 $2.68 Million
Q3 2023 Nov 07, 2023	BUY	$19.86 - $26.93 $858,627 - $1.16 Million	43,234 Added 68.94%	105,949 $2.68 Million
Q2 2023 Oct 21, 2024	SELL	$16.44 - $21.1 $530,107 - $680,369	-32,245 Reduced 33.96%	62,715 $1.32 Million
Q2 2023 Aug 07, 2023	BUY	$16.44 - $21.1 $1.03 Million - $1.32 Million	62,715 New	62,715 $1.32 Million
Q4 2022 Feb 13, 2023	SELL	$16.98 - $23.15 $620,143 - $845,484	-36,522 Reduced 33.5%	72,490 $1.45 Million
Q3 2022 Nov 07, 2022	BUY	$20.88 - $28.21 $1.24 Million - $1.67 Million	59,195 Added 118.82%	109,012 $2.35 Million
Q2 2022 Aug 09, 2022	SELL	$17.07 - $25.71 $870,279 - $1.31 Million	-50,983 Reduced 50.58%	49,817 $983,000
Q1 2022 May 12, 2022	BUY	$20.42 - $28.13 $1.28 Million - $1.76 Million	62,560 Added 163.6%	100,800 $2.37 Million
Q4 2021 Feb 10, 2022	BUY	$25.89 - $33.45 $360,906 - $466,293	13,940 Added 57.37%	38,240 $1.04 Million
Q3 2021 Nov 12, 2021	BUY	$22.46 - $29.47 $545,778 - $716,121	24,300 New	24,300 $669,000

465

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.